Cite

HARVARD Citation

    Soleimani, A. et al. (2022). CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leukemia & lymphoma. 63 (4), pp. 911-917. [Online]. 
  
Back to record